Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa (clinicaltrials.gov) - Oct 17, 2026 - P2 | N=248 | Completed | Sponsor: Novartis Pharmaceuticals | Active, not recruiting ➔ Completed | Trial completion date: Dec 2026 ➔ Sep 2026
Trial completion • Trial completion date • Dermatology • Hidradenitis Suppurativa • Immunology
|